Roseola epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 16: Line 16:


===Age===
===Age===
Roseola is an illness of young children with a peak prevalence between 7 and 13 months.<ref name="pmid13958107">{{cite journal| author=JURETIC M| title=Exanthema subitum a review of 243 cases. | journal=Helv Paediatr Acta | year= 1963 | volume= 18 | issue=  | pages= 80-95 | pmid=13958107 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13958107  }} </ref>
Roseola commonly affects young children between the ages of 7 and 13 months.<ref name="pmid13958107">{{cite journal| author=JURETIC M| title=Exanthema subitum a review of 243 cases. | journal=Helv Paediatr Acta | year= 1963 | volume= 18 | issue=  | pages= 80-95 | pmid=13958107 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13958107  }} </ref>


===Gender===
===Gender===

Revision as of 13:33, 24 May 2017

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola epidemiology and demographics

CDC on Roseola epidemiology and demographics

Roseola epidemiology and demographics in the news

Blogs on Roseola epidemiology and demographics

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Epidemiology and demographics

Prevalence

  • HHV-6 infection is detected in more than 90% of adult populations in developed countries.

Incidence

Case fatality rate

Age

Roseola commonly affects young children between the ages of 7 and 13 months.[1]

Gender

  • Roseola occurs equally in boys and girls.[2]

Race

Developed countries

Developing countries

References

  1. JURETIC M (1963). "Exanthema subitum a review of 243 cases". Helv Paediatr Acta. 18: 80–95. PMID 13958107.
  2. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T; et al. (1994). "Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum)". Pediatrics. 93 (1): 104–8. PMID 8265302.